

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 5.36159496 |
| 2 | cellular extravasation (GO:0045123) | 4.69201638 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.62937254 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.62937254 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 4.62937254 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.62937254 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.62937254 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.62937254 |
| 9 | detection of other organism (GO:0098543) | 4.29195228 |
| 10 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.18926746 |
| 11 | response to muramyl dipeptide (GO:0032495) | 4.17609619 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.16509454 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.16509454 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.14522331 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.03186750 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.00817698 |
| 17 | detection of bacterium (GO:0016045) | 3.96578599 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 3.95080455 |
| 19 | detection of molecule of bacterial origin (GO:0032490) | 3.75396493 |
| 20 | negative regulation of interleukin-12 production (GO:0032695) | 3.74342501 |
| 21 | detection of external biotic stimulus (GO:0098581) | 3.65542857 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.61640515 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.54812546 |
| 24 | response to laminar fluid shear stress (GO:0034616) | 3.49974575 |
| 25 | leukocyte aggregation (GO:0070486) | 3.47421053 |
| 26 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.43131728 |
| 27 | detection of biotic stimulus (GO:0009595) | 3.38920405 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.33296669 |
| 29 | germinal center formation (GO:0002467) | 3.29432453 |
| 30 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.28685855 |
| 31 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.25484344 |
| 32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.24406392 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.22194703 |
| 34 | response to host immune response (GO:0052572) | 3.22194703 |
| 35 | regulation of mast cell degranulation (GO:0043304) | 3.21527810 |
| 36 | response to host (GO:0075136) | 3.19763325 |
| 37 | response to host defenses (GO:0052200) | 3.19763325 |
| 38 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.19763325 |
| 39 | neutrophil mediated immunity (GO:0002446) | 3.15423058 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.09298150 |
| 41 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.06959152 |
| 42 | neutrophil activation (GO:0042119) | 3.06298580 |
| 43 | regulation of leukocyte degranulation (GO:0043300) | 3.03850107 |
| 44 | granulocyte activation (GO:0036230) | 3.02219109 |
| 45 | macrophage activation (GO:0042116) | 3.00312546 |
| 46 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.96390916 |
| 47 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.95671890 |
| 48 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.94092343 |
| 49 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.93996092 |
| 50 | myeloid cell activation involved in immune response (GO:0002275) | 2.91802256 |
| 51 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.91761422 |
| 52 | negative regulation of interleukin-6 production (GO:0032715) | 2.90802393 |
| 53 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.90567289 |
| 54 | respiratory burst (GO:0045730) | 2.90230637 |
| 55 | tolerance induction (GO:0002507) | 2.86378882 |
| 56 | immunoglobulin mediated immune response (GO:0016064) | 2.85346578 |
| 57 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.83548835 |
| 58 | negative regulation of interleukin-8 production (GO:0032717) | 2.82863837 |
| 59 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.78554392 |
| 60 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.76353698 |
| 61 | regulation of macrophage cytokine production (GO:0010935) | 2.74235021 |
| 62 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.72865683 |
| 63 | embryonic process involved in female pregnancy (GO:0060136) | 2.69615383 |
| 64 | regulation of mast cell activation (GO:0033003) | 2.67563371 |
| 65 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.65276911 |
| 66 | protein localization to endosome (GO:0036010) | 2.64975258 |
| 67 | pinocytosis (GO:0006907) | 2.64315567 |
| 68 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.64082653 |
| 69 | NIK/NF-kappaB signaling (GO:0038061) | 2.61279619 |
| 70 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.61000169 |
| 71 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.60662053 |
| 72 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.59802042 |
| 73 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.55974171 |
| 74 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.55237388 |
| 75 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.55237388 |
| 76 | mannose metabolic process (GO:0006013) | 2.55203599 |
| 77 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.54531990 |
| 78 | positive regulation of mast cell activation (GO:0033005) | 2.54193202 |
| 79 | microglial cell activation (GO:0001774) | 2.53935811 |
| 80 | regulation of tolerance induction (GO:0002643) | 2.53663294 |
| 81 | regulation of T cell tolerance induction (GO:0002664) | 2.53239563 |
| 82 | defense response to protozoan (GO:0042832) | 2.51962147 |
| 83 | myeloid leukocyte mediated immunity (GO:0002444) | 2.51656331 |
| 84 | T-helper 1 type immune response (GO:0042088) | 2.50155182 |
| 85 | negative regulation of T cell mediated immunity (GO:0002710) | 2.49427240 |
| 86 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.48742145 |
| 87 | hypotonic response (GO:0006971) | 2.47989542 |
| 88 | cellular response to type I interferon (GO:0071357) | 2.47366698 |
| 89 | type I interferon signaling pathway (GO:0060337) | 2.47366698 |
| 90 | neutrophil chemotaxis (GO:0030593) | 2.46789959 |
| 91 | response to type I interferon (GO:0034340) | 2.45902361 |
| 92 | leukocyte degranulation (GO:0043299) | 2.45250334 |
| 93 | negative regulation of innate immune response (GO:0045824) | 2.44738067 |
| 94 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.43112106 |
| 95 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.42579466 |
| 96 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.40277015 |
| 97 | neutrophil migration (GO:1990266) | 2.39663926 |
| 98 | regulation of interleukin-6 production (GO:0032675) | 2.39457781 |
| 99 | regulation of necroptotic process (GO:0060544) | 2.38954410 |
| 100 | establishment of endothelial barrier (GO:0061028) | 2.37448157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.56760820 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.45838977 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.21555493 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.17484349 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.03201339 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.00596168 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.90835862 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.82986434 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.79434225 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.77181157 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.75515666 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58964190 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.51175600 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.44952675 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.44587638 |
| 16 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.43872703 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.36688714 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.27748647 |
| 19 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.24643197 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.24028713 |
| 21 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.18165968 |
| 22 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.15473019 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.13729627 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.11449404 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.08994067 |
| 26 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.05847323 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.01273418 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.91874717 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91126529 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.90801487 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.89869228 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.89835953 |
| 33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.89424854 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86922336 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86477965 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84319968 |
| 37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.81727016 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.79133165 |
| 39 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.77023933 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.74281411 |
| 41 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.73404571 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.71316894 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.69195590 |
| 44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65332957 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63352234 |
| 46 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.63278985 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.60996618 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60360111 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58002098 |
| 50 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.57422013 |
| 51 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.56410086 |
| 52 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.56144243 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.54405634 |
| 54 | MYB_26560356_Chip-Seq_TH2_Human | 1.54297889 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.51807239 |
| 56 | * MYB_26560356_Chip-Seq_TH1_Human | 1.49418854 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.45077858 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.44303152 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43947362 |
| 60 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32886428 |
| 61 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.31367663 |
| 62 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30331506 |
| 63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29538668 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.29015779 |
| 65 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28113838 |
| 66 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.24712736 |
| 67 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.21931158 |
| 68 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19017763 |
| 69 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18597413 |
| 70 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18597413 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17059147 |
| 72 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.17016767 |
| 73 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.16627165 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14252372 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14065391 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11628100 |
| 77 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11227489 |
| 78 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10672879 |
| 79 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10029401 |
| 80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.09956650 |
| 81 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08485917 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08444086 |
| 83 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.07843371 |
| 84 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07796589 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06127422 |
| 86 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05870356 |
| 87 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05408483 |
| 88 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04583064 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04069130 |
| 90 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02964031 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02801726 |
| 92 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.02607487 |
| 93 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02266071 |
| 94 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.98935523 |
| 95 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.98147940 |
| 96 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96771338 |
| 97 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95243171 |
| 98 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.93613561 |
| 99 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.93496322 |
| 100 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93217504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.91054366 |
| 2 | MP0003724_increased_susceptibility_to | 3.38188427 |
| 3 | MP0003303_peritoneal_inflammation | 3.06502599 |
| 4 | MP0003828_pulmonary_edema | 2.76598083 |
| 5 | MP0002419_abnormal_innate_immunity | 2.57189755 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.50119510 |
| 7 | MP0009278_abnormal_bone_marrow | 2.41727465 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.38259912 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.28860394 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.28379684 |
| 11 | MP0003566_abnormal_cell_adhesion | 2.17216687 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.17069055 |
| 13 | MP0008260_abnormal_autophagy | 2.15517815 |
| 14 | MP0004947_skin_inflammation | 2.12191497 |
| 15 | MP0005025_abnormal_response_to | 2.12137650 |
| 16 | MP0000685_abnormal_immune_system | 2.07590822 |
| 17 | MP0001533_abnormal_skeleton_physiology | 2.04175479 |
| 18 | MP0009785_altered_susceptibility_to | 2.02123918 |
| 19 | MP0004510_myositis | 1.95263856 |
| 20 | MP0001790_abnormal_immune_system | 1.92324579 |
| 21 | MP0005387_immune_system_phenotype | 1.92324579 |
| 22 | MP0001800_abnormal_humoral_immune | 1.88459588 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.87297355 |
| 24 | MP0002723_abnormal_immune_serum | 1.85230281 |
| 25 | MP0006082_CNS_inflammation | 1.84671428 |
| 26 | MP0003091_abnormal_cell_migration | 1.83025494 |
| 27 | MP0005451_abnormal_body_composition | 1.81000249 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.80825837 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.79865862 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.79843146 |
| 31 | MP0001819_abnormal_immune_cell | 1.77791579 |
| 32 | MP0005076_abnormal_cell_differentiation | 1.76265597 |
| 33 | MP0009840_abnormal_foam_cell | 1.73705125 |
| 34 | MP0002405_respiratory_system_inflammati | 1.73398265 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.71446935 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.66962823 |
| 37 | MP0002998_abnormal_bone_remodeling | 1.66748685 |
| 38 | MP0001851_eye_inflammation | 1.63027969 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.61368798 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.61368798 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.52495705 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.51899837 |
| 43 | MP0003279_aneurysm | 1.51745728 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.51485914 |
| 45 | MP0000858_altered_metastatic_potential | 1.50155019 |
| 46 | MP0005164_abnormal_response_to | 1.46878129 |
| 47 | MP0009764_decreased_sensitivity_to | 1.43067451 |
| 48 | MP0002398_abnormal_bone_marrow | 1.37747980 |
| 49 | MP0005023_abnormal_wound_healing | 1.37425099 |
| 50 | MP0000343_altered_response_to | 1.36858683 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.36168149 |
| 52 | MP0005671_abnormal_response_to | 1.35829701 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.35475415 |
| 54 | MP0000716_abnormal_immune_system | 1.32294981 |
| 55 | MP0003453_abnormal_keratinocyte_physiol | 1.30668188 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.30182990 |
| 57 | MP0001853_heart_inflammation | 1.28481786 |
| 58 | MP0003448_altered_tumor_morphology | 1.27215717 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.27060672 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.25186004 |
| 61 | MP0002396_abnormal_hematopoietic_system | 1.24002679 |
| 62 | MP0004883_abnormal_blood_vessel | 1.23561554 |
| 63 | MP0005390_skeleton_phenotype | 1.20591401 |
| 64 | MP0001958_emphysema | 1.18964114 |
| 65 | MP0002722_abnormal_immune_system | 1.16431141 |
| 66 | * MP0003075_altered_response_to | 1.14378844 |
| 67 | MP0000767_abnormal_smooth_muscle | 1.13818666 |
| 68 | MP0002877_abnormal_melanocyte_morpholog | 1.13302517 |
| 69 | MP0002166_altered_tumor_susceptibility | 1.12837275 |
| 70 | MP0002332_abnormal_exercise_endurance | 1.11246707 |
| 71 | MP0002429_abnormal_blood_cell | 1.10347421 |
| 72 | MP0002060_abnormal_skin_morphology | 1.09861204 |
| 73 | MP0008469_abnormal_protein_level | 1.08459905 |
| 74 | MP0002009_preneoplasia | 1.08426925 |
| 75 | MP0008004_abnormal_stomach_pH | 1.07124874 |
| 76 | MP0005166_decreased_susceptibility_to | 1.06241744 |
| 77 | MP0002933_joint_inflammation | 1.06138958 |
| 78 | MP0000689_abnormal_spleen_morphology | 1.03743252 |
| 79 | MP0010352_gastrointestinal_tract_polyps | 1.02043930 |
| 80 | MP0000703_abnormal_thymus_morphology | 1.00104399 |
| 81 | MP0000249_abnormal_blood_vessel | 0.98183831 |
| 82 | MP0005275_abnormal_skin_tensile | 0.97686190 |
| 83 | MP0002796_impaired_skin_barrier | 0.91903271 |
| 84 | MP0002132_abnormal_respiratory_system | 0.90368495 |
| 85 | MP0002006_tumorigenesis | 0.89281843 |
| 86 | MP0010368_abnormal_lymphatic_system | 0.88584322 |
| 87 | MP0005409_darkened_coat_color | 0.85753573 |
| 88 | MP0003795_abnormal_bone_structure | 0.81563959 |
| 89 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81142396 |
| 90 | MP0004381_abnormal_hair_follicle | 0.80908131 |
| 91 | MP0001849_ear_inflammation | 0.80368015 |
| 92 | MP0009763_increased_sensitivity_to | 0.80002059 |
| 93 | MP0003950_abnormal_plasma_membrane | 0.79260972 |
| 94 | MP0001542_abnormal_bone_strength | 0.78511217 |
| 95 | MP0003045_fibrosis | 0.77443051 |
| 96 | MP0005310_abnormal_salivary_gland | 0.75672738 |
| 97 | MP0009931_abnormal_skin_appearance | 0.73645623 |
| 98 | MP0002254_reproductive_system_inflammat | 0.73054172 |
| 99 | * MP0005621_abnormal_cell_physiology | 0.72819589 |
| 100 | MP0000604_amyloidosis | 0.72720713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.92840214 |
| 2 | Abnormality of macrophages (HP:0004311) | 4.16806548 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 3.92148109 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.82214255 |
| 5 | Myositis (HP:0100614) | 3.82207581 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.79980141 |
| 7 | Orchitis (HP:0100796) | 3.60904396 |
| 8 | Increased IgE level (HP:0003212) | 3.22357695 |
| 9 | Stomatitis (HP:0010280) | 3.19246614 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 3.16950483 |
| 11 | Optic neuritis (HP:0100653) | 3.16950483 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.04417384 |
| 13 | Spontaneous hematomas (HP:0007420) | 2.97284458 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 2.90843802 |
| 15 | Cellulitis (HP:0100658) | 2.81977019 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 2.77610071 |
| 17 | Amyloidosis (HP:0011034) | 2.76199620 |
| 18 | Peritonitis (HP:0002586) | 2.76037128 |
| 19 | Recurrent fungal infections (HP:0002841) | 2.69156775 |
| 20 | Protrusio acetabuli (HP:0003179) | 2.63695835 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.60840109 |
| 22 | Urticaria (HP:0001025) | 2.58053869 |
| 23 | Recurrent skin infections (HP:0001581) | 2.57920587 |
| 24 | Episodic fever (HP:0001954) | 2.54938816 |
| 25 | Gingivitis (HP:0000230) | 2.54511918 |
| 26 | Abnormality of glycolipid metabolism (HP:0010969) | 2.51416129 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.51416129 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.51416129 |
| 29 | Keratoconjunctivitis sicca (HP:0001097) | 2.50514977 |
| 30 | Increased connective tissue (HP:0009025) | 2.48963092 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 2.45592981 |
| 32 | Obstructive lung disease (HP:0006536) | 2.45592981 |
| 33 | Polycythemia (HP:0001901) | 2.44178461 |
| 34 | Spondylolisthesis (HP:0003302) | 2.41616250 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.40473687 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 2.40473687 |
| 37 | Premature rupture of membranes (HP:0001788) | 2.36553790 |
| 38 | Vasculitis (HP:0002633) | 2.31630597 |
| 39 | Meningitis (HP:0001287) | 2.31301745 |
| 40 | Vertebral compression fractures (HP:0002953) | 2.27975077 |
| 41 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.27727041 |
| 42 | Pustule (HP:0200039) | 2.27470858 |
| 43 | Broad face (HP:0000283) | 2.26448589 |
| 44 | Dilatation of the ascending aorta (HP:0005111) | 2.25732203 |
| 45 | Keratoconjunctivitis (HP:0001096) | 2.25239269 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.22869967 |
| 47 | Pulmonary infiltrates (HP:0002113) | 2.20305387 |
| 48 | Epistaxis (HP:0000421) | 2.20118208 |
| 49 | Distal lower limb amyotrophy (HP:0008944) | 2.18908323 |
| 50 | Chest pain (HP:0100749) | 2.18122571 |
| 51 | Interstitial pulmonary disease (HP:0006530) | 2.17242520 |
| 52 | Aortic aneurysm (HP:0004942) | 2.16954616 |
| 53 | Loss of speech (HP:0002371) | 2.13932093 |
| 54 | Cerebral aneurysm (HP:0004944) | 2.12613060 |
| 55 | Thick nail (HP:0001805) | 2.10375111 |
| 56 | Fatigue (HP:0012378) | 2.10286323 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.10101662 |
| 58 | Hemoptysis (HP:0002105) | 2.08905723 |
| 59 | Myocardial infarction (HP:0001658) | 2.08381951 |
| 60 | Abnormality of the peritoneum (HP:0002585) | 2.07769530 |
| 61 | Arterial thrombosis (HP:0004420) | 2.05983985 |
| 62 | Dysostosis multiplex (HP:0000943) | 2.05145019 |
| 63 | Distal lower limb muscle weakness (HP:0009053) | 2.02106112 |
| 64 | Leukocytosis (HP:0001974) | 2.01069294 |
| 65 | Recurrent viral infections (HP:0004429) | 2.00316289 |
| 66 | Increased variability in muscle fiber diameter (HP:0003557) | 1.97286070 |
| 67 | Gingival bleeding (HP:0000225) | 1.95764997 |
| 68 | Subacute progressive viral hepatitis (HP:0006572) | 1.94293509 |
| 69 | Osteomyelitis (HP:0002754) | 1.92616617 |
| 70 | Hematochezia (HP:0002573) | 1.90938958 |
| 71 | Skin ulcer (HP:0200042) | 1.90406391 |
| 72 | Disproportionate tall stature (HP:0001519) | 1.89215579 |
| 73 | Slow saccadic eye movements (HP:0000514) | 1.86651828 |
| 74 | Glomerulopathy (HP:0100820) | 1.86586998 |
| 75 | Syringomyelia (HP:0003396) | 1.86471651 |
| 76 | Spinal cord lesions (HP:0100561) | 1.86471651 |
| 77 | Hypergammaglobulinemia (HP:0010702) | 1.84417486 |
| 78 | Muscle fiber splitting (HP:0003555) | 1.84357518 |
| 79 | Osteolytic defects of the hand bones (HP:0009699) | 1.84139817 |
| 80 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.84139817 |
| 81 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.83446401 |
| 82 | Abnormal platelet volume (HP:0011876) | 1.82357228 |
| 83 | Atrophic scars (HP:0001075) | 1.82352568 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 1.81809368 |
| 85 | Aortic dissection (HP:0002647) | 1.81807708 |
| 86 | Increased serum ferritin (HP:0003281) | 1.81467335 |
| 87 | Dislocated radial head (HP:0003083) | 1.81083813 |
| 88 | Aneurysm (HP:0002617) | 1.79517784 |
| 89 | Difficulty climbing stairs (HP:0003551) | 1.78919942 |
| 90 | Polygenic inheritance (HP:0010982) | 1.77284748 |
| 91 | Anorexia (HP:0002039) | 1.76424921 |
| 92 | Granulocytopenia (HP:0001913) | 1.76317986 |
| 93 | Inflammation of the large intestine (HP:0002037) | 1.75279129 |
| 94 | Cervical subluxation (HP:0003308) | 1.75151343 |
| 95 | Genu recurvatum (HP:0002816) | 1.74575469 |
| 96 | Encephalitis (HP:0002383) | 1.74390043 |
| 97 | Asymmetric septal hypertrophy (HP:0001670) | 1.73978776 |
| 98 | Abnormality of the pericardium (HP:0001697) | 1.73695936 |
| 99 | Fragile skin (HP:0001030) | 1.72236429 |
| 100 | Gastrointestinal inflammation (HP:0004386) | 1.71933942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.55037053 |
| 2 | MAP2K3 | 3.23477301 |
| 3 | RIPK4 | 2.91819855 |
| 4 | ERN1 | 2.88868198 |
| 5 | MAP3K3 | 2.48836550 |
| 6 | IRAK4 | 2.43965084 |
| 7 | BLK | 2.41317454 |
| 8 | EPHB1 | 2.38835785 |
| 9 | MAP4K1 | 2.19210632 |
| 10 | ZAP70 | 2.09341060 |
| 11 | IRAK3 | 2.08406929 |
| 12 | TYK2 | 1.92485685 |
| 13 | MAP3K14 | 1.91898433 |
| 14 | CSK | 1.87526013 |
| 15 | TTN | 1.76691801 |
| 16 | TRIB3 | 1.74182306 |
| 17 | TAOK2 | 1.74057484 |
| 18 | TGFBR2 | 1.67891227 |
| 19 | JAK3 | 1.67525386 |
| 20 | TAOK1 | 1.65587727 |
| 21 | CDK12 | 1.64092726 |
| 22 | MAP3K13 | 1.61188981 |
| 23 | IKBKE | 1.45518277 |
| 24 | FES | 1.43803140 |
| 25 | TBK1 | 1.43117401 |
| 26 | SIK1 | 1.41482555 |
| 27 | GRK6 | 1.40485347 |
| 28 | MAP3K1 | 1.39766512 |
| 29 | MAP3K6 | 1.39300568 |
| 30 | MAP3K11 | 1.38633383 |
| 31 | IRAK1 | 1.31296812 |
| 32 | IRAK2 | 1.27104101 |
| 33 | HCK | 1.27067614 |
| 34 | SIK3 | 1.21378316 |
| 35 | MAPK7 | 1.19634977 |
| 36 | ICK | 1.18568598 |
| 37 | RIPK1 | 1.18302170 |
| 38 | MARK2 | 1.17196833 |
| 39 | KSR2 | 1.15093659 |
| 40 | MOS | 1.14300070 |
| 41 | PRKD2 | 1.13633481 |
| 42 | SMG1 | 1.10711127 |
| 43 | BTK | 1.10495607 |
| 44 | FGR | 1.01709836 |
| 45 | IKBKB | 0.99357735 |
| 46 | CDC42BPA | 0.96307737 |
| 47 | JAK1 | 0.94696440 |
| 48 | MAPK12 | 0.91115525 |
| 49 | PDK2 | 0.90928596 |
| 50 | STK10 | 0.89648463 |
| 51 | KIT | 0.87635595 |
| 52 | PTK6 | 0.87049871 |
| 53 | BMPR2 | 0.86166473 |
| 54 | SYK | 0.85953903 |
| 55 | JAK2 | 0.82798015 |
| 56 | TNK2 | 0.78811618 |
| 57 | MAP3K7 | 0.77253852 |
| 58 | PDGFRB | 0.75639754 |
| 59 | LCK | 0.74495741 |
| 60 | RPS6KC1 | 0.73897076 |
| 61 | RPS6KL1 | 0.73897076 |
| 62 | PIK3CG | 0.73728225 |
| 63 | PIM2 | 0.72225060 |
| 64 | TXK | 0.72140431 |
| 65 | MARK3 | 0.71559405 |
| 66 | PDPK1 | 0.71484930 |
| 67 | PAK4 | 0.71103539 |
| 68 | HIPK2 | 0.68875712 |
| 69 | CHUK | 0.67628415 |
| 70 | LYN | 0.67570553 |
| 71 | YES1 | 0.66592224 |
| 72 | MTOR | 0.64608481 |
| 73 | ITK | 0.62862638 |
| 74 | PTK2B | 0.61597381 |
| 75 | CAMK1D | 0.60997802 |
| 76 | CLK1 | 0.60891304 |
| 77 | RAF1 | 0.58420457 |
| 78 | WNK1 | 0.58387075 |
| 79 | PDGFRA | 0.57629470 |
| 80 | RPS6KA6 | 0.57437595 |
| 81 | FGFR4 | 0.55188431 |
| 82 | STK38 | 0.54869555 |
| 83 | PDK1 | 0.54827812 |
| 84 | MAPKAPK2 | 0.54406234 |
| 85 | RPS6KA2 | 0.53657009 |
| 86 | EPHA3 | 0.52938514 |
| 87 | MATK | 0.52331930 |
| 88 | TESK2 | 0.52323571 |
| 89 | PTK2 | 0.52259878 |
| 90 | TRPM7 | 0.51319225 |
| 91 | MAP3K8 | 0.50897494 |
| 92 | SGK3 | 0.49633912 |
| 93 | PIM1 | 0.49254450 |
| 94 | MAP3K5 | 0.48868553 |
| 95 | MAP3K2 | 0.47931870 |
| 96 | CDK6 | 0.47357101 |
| 97 | CSF1R | 0.46843455 |
| 98 | BMX | 0.44572754 |
| 99 | ARAF | 0.44561410 |
| 100 | GSK3A | 0.44323349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.62331758 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.34602203 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.26180365 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.18081424 |
| 5 | Malaria_Homo sapiens_hsa05144 | 2.05503526 |
| 6 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.92084919 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.84540486 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.80439863 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.80432169 |
| 10 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.74717488 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.72470766 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.71193681 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68055330 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.63447577 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.62060006 |
| 16 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.59995703 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58351668 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.50386183 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.46611526 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46135641 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.45512628 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.44928497 |
| 23 | Hepatitis B_Homo sapiens_hsa05161 | 1.38835204 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.37834485 |
| 25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.36231570 |
| 26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.35221317 |
| 27 | Amoebiasis_Homo sapiens_hsa05146 | 1.34366663 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31040929 |
| 29 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.29921618 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29673456 |
| 31 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.28013827 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27726172 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.27131360 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.26815166 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.25138831 |
| 36 | Bladder cancer_Homo sapiens_hsa05219 | 1.25066358 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.23731917 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22970190 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.22412715 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.22312659 |
| 41 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.20364175 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19527566 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.16863219 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.12824177 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12624858 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12023862 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.08278958 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.08260998 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.06375270 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 1.06354858 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06251512 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 1.01009981 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.99875283 |
| 54 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99124761 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 0.97013080 |
| 56 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.94194060 |
| 57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92438116 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91309294 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90923199 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.89974624 |
| 61 | Focal adhesion_Homo sapiens_hsa04510 | 0.89179321 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87894203 |
| 63 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.87279268 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87170944 |
| 65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85218276 |
| 66 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.84365157 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84248786 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82153408 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79293859 |
| 70 | Prostate cancer_Homo sapiens_hsa05215 | 0.78943861 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78689012 |
| 72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.78351587 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77829125 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77718602 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74910417 |
| 76 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.74653857 |
| 77 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74463730 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74341358 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74198445 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.73711855 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73629151 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.72730534 |
| 83 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.71934976 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71354947 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70337673 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68245067 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67717014 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62192233 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59793517 |
| 90 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.59692938 |
| 91 | Pathways in cancer_Homo sapiens_hsa05200 | 0.59681383 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.58797492 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58406541 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.58203992 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57787093 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56535954 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56468963 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55707209 |
| 99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53940336 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52755345 |

